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low oxygen concentration (0.1-2%) has been known for some
time and yet the details of how the resident chondrocytes sense
and respond to hypoxia remain largely unknown. Our laboratory
showed that hypoxia restores the chondrocyte phenotype to ded-
ifferentiated chondrocytes. Because these findings emphasised
the possible pivotal role of hypoxia on chondrocytes, we de-
cided to answer the very basic question of how human articular
chondrocytes (HAC) respond to hypoxia.
Methods: We are using normal human articular chondrocytes
(HAC) isolated from knee joint in amputated limbs, patients aged
from 8 to 45 years. These chondrocytes are exposed to low
oxygen concentration. To assess involvement of HIF pathway,
siRNA technology has been used to knock-down HIF expression
in primary chondrocytes and chondrocytes markers expression
has been analysed.
Results: Exposure of normal HAC to low oxygen concentration
confirmed the possible pivotal role of hypoxia in chondrocytes
because Sox9 expression (the main transcription factor that
regulates matrix proteins expression) was highly up-regulated
within the first few days as well as matrix proteins (Collagen type
2 and Aggrecan).
Since hypoxia effects are mediated through transcription fac-
tors, namely HIF (Hypoxia Inducible Factor, whose expression
is stabilised when oxygen concentration is low), we investigated
whether Sox9 up-regulation by hypoxia was HIF dependent.
Initialy, we treated HAC with Deferoxamine, a hypoxia mimetic
factor (DFO is an iron chelator that inhibits hydroxylases respon-
sible of HIF degradation). Results show also a high up-regulation
of Sox9 protein suggesting a HIF involvement.
As a second more specific approach, we have invalidated HIF
signalling (HIF-1α and 2α) using the siRNA technology. Our data
suggests that the Sox9 increase under hypoxia is dependent
of the HIF1/2α factors suggesting a pivotal role for HIF on
chondrocytes phenotype.
Conclusions: Our results show that hypoxia exert positive effect
on chondrocyte phenotype as assessed by Sox9 up-regulation.
This effect is mediated through HIF pathway. We are now inves-
tigating whether other chondrocytes markers are dependent of
HIF pathway.
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Purpose: Culture-expanded bone marrow-derived human mes-
enchymal stem cells (hMSCs) can enter and progress along
the chondrogenic pathway when cultured in high-density 3-
dimensional aggregates in a defined medium that includes TGF-
beta 1. We have modified this culture system and converted it
into a high throughput system by using 96-well plates to replace
the original 15-ml tubes. This modification allows a significant de-
crease in the time and workload necessary for the establishment
and maintenance of the cultures allowing us to test complex
grids with multiple variables.
The application of stem cell-based therapies to cartilage repair
necessitates better understanding of the mechanisms that reg-
ulate generation and maintenance of cartilage as well as those
controlling specific phenotypic characteristics of different carti-
lage subtypes. In this regard, it has been reported that lineage
progression of hMSCs-derived chondrocytes towards a hyper-
trophic phenotype is regulated by TGF-beta and thyroxine. We
tested the effect of TGF-beta and dexamethasone on the hyper-
trophic differentiation of hMSC-derived chondrocytes
Methods: First passage hMSCs were introduced into aggregate
cultures. On day 7, a subset was kept in standard medium (con-
trol) while dexamethasone (-dex), TGF-beta 1 (-TGF) or both
dexamethasone and TGF-beta 1 (-dex -TGF) were withdrawn
from the medium in replicate sets. Aggregate sets were main-
tained in these conditions for up to 6 weeks. Two-, 3-, 4-, 5-
and 6-week aggregates were fixed, embedded, sectioned, and
stained with toluidine blue or immunostained with antibodies
against collagen type I, II and X and examined by microscopy.
Replicate aggregates were assayed for DNA and GAG content.
Results: Cells within the aggregates cultured in the absence of
TGF-beta 1 after day 7 of culture exhibited hypertrophic morphol-
ogy by day 21 with enlarged lacunae and dense interterritorial
matrix while those in TGF-beta 1-containing medium did not
exhibit these features. Aggregates in the -dex -TGF group pre-
sented more homogenous signs of hypertrophy throughout the
aggregates than those in the -TGF group. Aggregates cultured in
TGF-containing medium presented a peripheral Type X collagen-
negative layer with a thickness similar to the predicted diffusion
limit for TGF-beta 1 into the extracellular matrix of aggregates.
The DNA content of the aggregates remained constant over time
and was equivalent among the different treatment groups. In
contrast, the extracellular matrix, of aggregates cultured in -TGF
(with or without dex) medium accumulated more proteoglycan
than those cultured in TGF-containing medium, particularly than
those in -dex medium which displayed the least of proteoglycan
content.
Conclusions: The observations reported above lead us to pos-
tulate a key role for dexamethasone and TGF-beta 1 in chon-
drogenic lineage progression of hMSC-derived chondrocytes,
particularly in their progression towards hypertrophy. Further-
more, we have successfully developed a high-throughput assay
system to study aspects of chondrogenesis and chondrogenic
lineage progression.
Further studies are necessary to determine the molecular mech-
anism by which lineage progression and hypertrophic differenti-
ation are regulated and the signaling pathways involved in this
process. A better understanding of these mechanisms will allow
the development of specific culture conditions optimized for tar-
geted applications where different cartilage phenotypes might be
desired.
